Get the Latest Investment Ideas Delivered Straight to Your Inbox. Subscribe

News Update


Drone Firm Chosen to Integrate Breakthrough Health Diagnosis Technology in Fight Against Coronavirus

Share on Stocktwits


Draganfly and its partners aim to rapidly deploy the groundbreaking technology so it can help combat COVID-19.

In a news release, Draganfly Inc. (DFLY:CSE; DFLYF:OTCQB), which specializes in unmanned vehicle technology, announced it was chosen as the exclusive integration partner on a project aimed at combating COVID-19 and future health crises.

The Vital Intelligence Project combines a health and respiratory monitoring platform with new and existing camera networks and unmanned aerial vehicles (UAVs) and remotely piloted aircraft. The automated equipment monitors people's health and vital signs, including temperature, heart rate and respiratory rate, and detects respiratory and infectious conditions.

The monitoring devices are ideal for use among crowds, workforces and at-risk groups, such as seniors, at care facilities for example, and high-traffic places, including airports, convention centers, cruise ships, border crossings and critical infrastructure facilities. Also, the data they collect can help in understanding certain health trends.

Draganfly's role is to use its engineering, integration and distribution expertise and secure supply chain to commercialize and deploy the technology right away. Accordingly, the Canadian company signed a binding agreement, which affords an initial $1.5 million-plus budget.

The other partner in the project is Vital Intelligence Inc., a healthcare data services and deep learning company associated with the University of South Australia, which developed the technology with help from the Australian Department of Defense's Defense Science and Technology Group.

"With fighting epidemics rising as a global priority, new versatile technologies, such as humanitarian mission UAVs, are immediately needed to detect and track outbreaks so that critical interventions can be deployed sooner and with greater effectiveness," Dr. Jack Chow, adviser to the Vital Intelligence Project and the former first assistant director-general of the World Health Organization, said in the release.

"Draganfly has been selected because of its proven leadership in an industry so important to public safety at such a critical time. We look forward to working with global agencies and industry to rapidly deploy this important technology," said Cameron Chell, CEO of Draganfly.

"Draganfly is honored to work on such an important project given the current pandemic facing the world with COVID-19. Health and respiratory monitoring will be vital for not only detection, but also utilizing the data to understand health trends. As we move forward, drones and autonomous technology doing detection will be an important part of ensuring public safety," said Andy Card, Director of Draganfly and former Secretary of Transportation and White House Chief of Staff.



1) Doresa Banning compiled this article for Streetwise Reports LLC and provides services to Streetwise Reports as an independent contractor. She or members of her household own securities of the following companies mentioned in the article: None. She or members of her household are paid by the following companies mentioned in this article: None.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Click here for important disclosures about sponsor fees.
3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article until three business days after the publication of the interview or article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases. As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of Draganfly, a company mentioned in this article.

Want to read more about Life Sciences Tools & Diagnostics investment ideas?
Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe